Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations

Journal of Proteome Research

Volumn 14, Issue 3, 2015, Pages 1535-1546

  Hammond, Dean E ^a   Mageean, Craig J ^a   Rusilowicz, Emma V ^a   Wickenden, Julie A ^b   Clague, Michael J ^a   Prior, Ian A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Molecular Biotechnology Center   (United Kingdom)

Author keywords

colorectal cancer; isogenic cells; Ras; signaling; SILAC phosphoproteomics

Indexed keywords

DOUBLECORTIN LIKE KINASE 1; K RAS PROTEIN; PHOSPHOTRANSFERASE; PROTEOME; UNCLASSIFIED DRUG; DCLK1 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

ALLELE; ARTICLE; CANCER CELL; CLUSTER ANALYSIS; CODON; COLORECTAL CANCER; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEAR REPROGRAMMING; ONCOGENE K RAS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; UPREGULATION; COLORECTAL TUMOR; GENETICS; METABOLISM; MUTATION; ONCOGENE RAS; PATHOLOGY; PROTEOMICS; TUMOR CELL LINE;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; GENES, RAS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MUTATION; PROTEIN-SERINE-THREONINE KINASES; PROTEOMICS; UP-REGULATION;

EID: 84924359443     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr501191a     Document Type: Article

References (60)

1. Quinlan, M. P.; Settleman, J. Isoform-specific ras functions in development and cancer Future Oncol. 2009, 5, 105-16
2. Prior, I. A.; Lewis, P. D.; Mattos, C. A comprehensive survey of Ras mutations in cancer Cancer Res. 2012, 72, 2457-67
3. Guerrero, S.; Casanova, I.; Farre, L.; Mazo, A.; Capella, G.; Mangues, R. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression Cancer Res. 2000, 60, 6750-6
4. Finkelstein, S. D.; Sayegh, R.; Christensen, S.; Swalsky, P. A. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type Cancer 1993, 71, 3827-38
5. Bazan, V.; Migliavacca, M.; Zanna, I.; Tubiolo, C.; Grassi, N.; Latteri, M. A.; La Farina, M.; Albanese, I.; Dardanoni, G.; Salerno, S.; Tomasino, R. M.; Labianca, R.; Gebbia, N.; Russo, A. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype Ann. Oncol 2002, 13, 1438-46
6. De Roock, W.; Jonker, D. J.; Di Nicolantonio, F.; Sartore-Bianchi, A.; Tu, D.; Siena, S.; Lamba, S.; Arena, S.; Frattini, M.; Piessevaux, H.; Van Cutsem, E.; O'Callaghan, C. J.; Khambata-Ford, S.; Zalcberg, J. R.; Simes, J.; Karapetis, C. S.; Bardelli, A.; Tejpar, S. Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab JAMA, J. Am. Med. Assoc. 2010, 304, 1812-20
7. Tejpar, S.; Celik, I.; Schlichting, M.; Sartorius, U.; Bokemeyer, C.; Van Cutsem, E. Association of KRAS G13D Tumor Mutations With Outcome in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy With or Without Cetuximab J. Clin. Oncol. 2012, 30, 3570-7
8. Seeburg, P. H.; Colby, W. W.; Capon, D. J.; Goeddel, D. V.; Levinson, A. D. Biological properties of human c-Ha-ras1 genes mutated at codon 12 Nature 1984, 312, 71-5
9. Trahey, M.; Milley, R. J.; Cole, G. E.; Innis, M.; Paterson, H.; Marshall, C. J.; Hall, A.; McCormick, F. Biochemical and biological properties of the human N-ras p21 protein Mol. Cell. Biol. 1987, 7, 541-4
10. John, J.; Frech, M.; Wittinghofer, A. Biochemical properties of Ha-ras encoded p21 mutants and mechanism of the autophosphorylation reaction J. Biol. Chem. 1988, 263, 11792-9
11. Araki, M.; Shima, F.; Yoshikawa, Y.; Muraoka, S.; Ijiri, Y.; Nagahara, Y.; Shirono, T.; Kataoka, T.; Tamura, A. Solution structure of the state 1 conformer of GTP-bound H-Ras protein and distinct dynamic properties between the state 1 and state 2 conformers J. Biol. Chem. 2011, 286, 39644-53
12. Muraoka, S.; Shima, F.; Araki, M.; Inoue, T.; Yoshimoto, A.; Ijiri, Y.; Seki, N.; Tamura, A.; Kumasaka, T.; Yamamoto, M.; Kataoka, T. Crystal structures of the state 1 conformations of the GTP-bound H-Ras protein and its oncogenic G12V and Q61L mutants FEBS Lett. 2012, 586, 1715-8
13. Spoerner, M.; Hozsa, C.; Poetzl, J. A.; Reiss, K.; Ganser, P.; Geyer, M.; Kalbitzer, H. R. Conformational states of human rat sarcoma (Ras) protein complexed with its natural ligand GTP and their role for effector interaction and GTP hydrolysis J. Biol. Chem. 2010, 285, 39768-78
14. Guha, U.; Chaerkady, R.; Marimuthu, A.; Patterson, A. S.; Kashyap, M. K.; Harsha, H. C.; Sato, M.; Bader, J. S.; Lash, A. E.; Minna, J. D.; Pandey, A.; Varmus, H. E. Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 14112-7
15. Sudhir, P. R.; Hsu, C. L.; Wang, M. J.; Wang, Y. T.; Chen, Y. J.; Sung, T. Y.; Hsu, W. L.; Yang, U. C.; Chen, J. Y. Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas PLoS One 2011, 6, e20199
16. Sweet-Cordero, A.; Mukherjee, S.; Subramanian, A.; You, H.; Roix, J. J.; Ladd-Acosta, C.; Mesirov, J.; Golub, T. R.; Jacks, T. An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis Nat. Genet. 2005, 37, 48-55
17. Tchernitsa, O. I.; Sers, C.; Zuber, J.; Hinzmann, B.; Grips, M.; Schramme, A.; Lund, P.; Schwendel, A.; Rosenthal, A.; Schafer, R. Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells Oncogene 2004, 23, 4536-55
18. Zuber, J.; Tchernitsa, O. I.; Hinzmann, B.; Schmitz, A. C.; Grips, M.; Hellriegel, M.; Sers, C.; Rosenthal, A.; Schafer, R. A genome-wide survey of RAS transformation targets Nat. Genet. 2000, 24, 144-52
19. Vartanian, S.; Bentley, C.; Brauer, M. J.; Li, L.; Shirasawa, S.; Sasazuki, T.; Kim, J. S.; Haverty, P.; Stawiski, E.; Modrusan, Z.; Waldman, T.; Stokoe, D. Identification of mutant KRas-dependent phenotypes using a panel of isogenic cell lines. J. Biol. Chem. 2013, in press
20. Singh, A.; Sweeney, M. F.; Yu, M.; Burger, A.; Greninger, P.; Benes, C.; Haber, D. A.; Settleman, J. TAK1 inhibition promotes apoptosis in KRAS-dependent colon cancers Cell 2012, 148, 639-50
21. Sato, M.; Vaughan, M. B.; Girard, L.; Peyton, M.; Lee, W.; Shames, D. S.; Ramirez, R. D.; Sunaga, N.; Gazdar, A. F.; Shay, J. W.; Minna, J. D. Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells Cancer Res. 2006, 66, 2116-28
22. Kim, J. S.; Lee, C.; Foxworth, A.; Waldman, T. B-Raf is dispensable for K-Ras-mediated oncogenesis in human cancer cells Cancer Res. 2004, 64, 1932-7
23. Shirasawa, S.; Furuse, M.; Yokoyama, N.; Sasazuki, T. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras Science 1993, 260, 85-8
24. Yun, J.; Rago, C.; Cheong, I.; Pagliarini, R.; Angenendt, P.; Rajagopalan, H.; Schmidt, K.; Willson, J. K.; Markowitz, S.; Zhou, S.; Diaz, L. A., Jr.; Velculescu, V. E.; Lengauer, C.; Kinzler, K. W.; Vogelstein, B.; Papadopoulos, N. Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells Science 2009, 325, 1555-9
25. Stöhr, G.; Tebbe, A. Quantitative LC-MS of proteins; Royal Society of Chemistry: Cambridge, 2011.
26. Omerovic, J.; Hammond, D. E.; Prior, I. A.; Clague, M. J. A global snap-shot of the influence of endocytosis upon EGF receptor signaling output J. Proteome Res. 2012, 11, 5157-5166
27. Wisniewski, J. R.; Zougman, A.; Nagaraj, N.; Mann, M. Universal sample preparation method for proteome analysis Nat. Methods 2009, 6, 359-62
28. Olsen, J. V.; Blagoev, B.; Gnad, F.; Macek, B.; Kumar, C.; Mortensen, P.; Mann, M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks Cell 2006, 127, 635-48
29. Olsen, J. V.; Macek, B. High accuracy mass spectrometry in large-scale analysis of protein phosphorylation Methods Mol. Biol. 2009, 492, 131-42
30. Hernandez-Valladares, M.; Aran, V.; Prior, I. A. Quantitative proteomic analysis of compartmentalized signaling networks Methods Enzymol. 2014, 535, 309-325
31. Cox, J.; Neuhauser, N.; Michalski, A.; Scheltema, R. A.; Olsen, J. V.; Mann, M. Andromeda: a peptide search engine integrated into the MaxQuant environment J. Proteome Res. 2011, 10, 1794-805
32. Cox, J.; Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification Nat. Biotechnol. 2008, 26, 1367-72
33. Rigbolt, K. T.; Vanselow, J. T.; Blagoev, B. GProX, a user-friendly platform for bioinformatics analysis and visualization of quantitative proteomics data Mol. Cell Proteomics 2011, 10 10.1074/mcp.O110.007450
34. Huang da, W.; Sherman, B. T.; Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources Nat. Protoc. 2009, 4, 44-57
35. Schwartz, D.; Gygi, S. P. An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets Nat. Biotechnol. 2005, 23, 1391-8
36. Linding, R.; Jensen, L. J.; Pasculescu, A.; Olhovsky, M.; Colwill, K.; Bork, P.; Yaffe, M. B.; Pawson, T. NetworKIN: a resource for exploring cellular phosphorylation networks Nucleic Acids Res. 2008, 36, D695-9
37. Iwata, S.; Lee, J. W.; Okada, K.; Lee, J. K.; Iwata, M.; Rasmussen, B.; Link, T. A.; Ramaswamy, S.; Jap, B. K. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex Science 1998, 281, 64-71
38. Snoeren, N.; Emmink, B. L.; Koerkamp, M. J.; van Hooff, S. R.; Goos, J. A.; van Houdt, W. J.; de Wit, M.; Prins, A. M.; Piersma, S. R.; Pham, T. V.; Belt, E. J.; Bril, H.; Stockmann, H. B.; Meijer, G. A.; van Hillegersberg, R.; Holstege, F. C.; Jimenez, C. R.; Fijneman, R. J.; Kranenburg, O. W.; Rinkes, I. H. Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer Br. J. Cancer 2013, 109, 1636-47
39. Nakanishi, Y.; Seno, H.; Fukuoka, A.; Ueo, T.; Yamaga, Y.; Maruno, T.; Nakanishi, N.; Kanda, K.; Komekado, H.; Kawada, M.; Isomura, A.; Kawada, K.; Sakai, Y.; Yanagita, M.; Kageyama, R.; Kawaguchi, Y.; Taketo, M. M.; Yonehara, S.; Chiba, T. Dclk1 distinguishes between tumor and normal stem cells in the intestine Nat. Genet. 2012, 45, 98-103
40. Burgess, H. A.; Reiner, O. Cleavage of doublecortin-like kinase by calpain releases an active kinase fragment from a microtubule anchorage domain J. Biol. Chem. 2001, 276, 36397-403
41. Akakura, S.; Gelman, I. H. Pivotal Role of AKAP12 in the Regulation of Cellular Adhesion Dynamics: Control of Cytoskeletal Architecture, Cell Migration, and Mitogenic Signaling J. Signal Transduction 2012, 2012, 529179
42. Basu Roy, U. K.; Henkhaus, R. S.; Loupakis, F.; Cremolini, C.; Gerner, E. W.; Ignatenko, N. A. Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis Int. J. Cancer 2013, 133, 43-57
43. Engelman, J. A.; Chu, C.; Lin, A.; Jo, H.; Ikezu, T.; Okamoto, T.; Kohtz, D. S.; Lisanti, M. P. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain FEBS Lett. 1998, 428, 205-11
44. Goetz, J. G.; Lajoie, P.; Wiseman, S. M.; Nabi, I. R. Caveolin-1 in tumor progression: the good, the bad and the ugly Cancer Metastasis Rev. 2008, 27, 715-35
45. Liu, W.; Guan, M.; Hu, T.; Gu, X.; Lu, Y. Re-expression of AKAP12 inhibits progression and metastasis potential of colorectal carcinoma in vivo and in vitro PLoS One 2011, 6, e24015
46. Parton, R. G.; del Pozo, M. A. Caveolae as plasma membrane sensors, protectors and organizers Nat. Rev. Mol. Cell Biol. 2013, 14, 98-112
47. Su, B.; Bu, Y.; Engelberg, D.; Gelman, I. H. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C-Raf/MEK/ERK pathway J. Biol. Chem. 2010, 285, 4578-86
48. Furge, K. A.; Kiewlich, D.; Le, P.; Vo, M. N.; Faure, M.; Howlett, A. R.; Lipson, K. E.; Woude, G. F.; Webb, C. P. Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 10722-7
49. Webb, C. P.; Taylor, G. A.; Jeffers, M.; Fiscella, M.; Oskarsson, M.; Resau, J. H.; Vande Woude, G. F. Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis Oncogene 1998, 17, 2019-25
50. Xie, T.; G, D. A.; Lamb, J. R.; Martin, E.; Wang, K.; Tejpar, S.; Delorenzi, M.; Bosman, F. T.; Roth, A. D.; Yan, P.; Bougel, S.; Di Narzo, A. F.; Popovici, V.; Budinska, E.; Mao, M.; Weinrich, S. L.; Rejto, P. A.; Hodgson, J. G. A comprehensive characterization of genome-wide copy number aberrations in colorectal cancer reveals novel oncogenes and patterns of alterations PLoS One 2012, 7, e42001
51. Prahallad, A.; Sun, C.; Huang, S.; Di Nicolantonio, F.; Salazar, R.; Zecchin, D.; Beijersbergen, R. L.; Bardelli, A.; Bernards, R. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR Nature 2012, 483, 100-3
52. Barretina, J.; Caponigro, G.; Stransky, N.; Venkatesan, K.; Margolin, A. A.; Kim, S.; Wilson, C. J.; Lehar, J.; Kryukov, G. V.; Sonkin, D.; Reddy, A.; Liu, M.; Murray, L.; Berger, M. F.; Monahan, J. E.; Morais, P.; Meltzer, J.; Korejwa, A.; Jane-Valbuena, J.; Mapa, F. A.; Thibault, J.; Bric-Furlong, E.; Raman, P.; Shipway, A.; Engels, I. H.; Cheng, J.; Yu, G. K.; Yu, J.; Aspesi, P., Jr.; de Silva, M.; Jagtap, K.; Jones, M. D.; Wang, L.; Hatton, C.; Palescandolo, E.; Gupta, S.; Mahan, S.; Sougnez, C.; Onofrio, R. C.; Liefeld, T.; MacConaill, L.; Winckler, W.; Reich, M.; Li, N.; Mesirov, J. P.; Gabriel, S. B.; Getz, G.; Ardlie, K.; Chan, V.; Myer, V. E.; Weber, B. L.; Porter, J.; Warmuth, M.; Finan, P.; Harris, J. L.; Meyerson, M.; Golub, T. R.; Morrissey, M. P.; Sellers, W. R.; Schlegel, R.; Garraway, L. A. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Nature 2012, 483, 603-7
53. Gagliardi, G.; Goswami, M.; Passera, R.; Bellows, C. F. DCLK1 immunoreactivity in colorectal neoplasia Clin. Exp. Gastroenterol. 2012, 5, 35-42
54. Luo, J.; Emanuele, M. J.; Li, D.; Creighton, C. J.; Schlabach, M. R.; Westbrook, T. F.; Wong, K. K.; Elledge, S. J. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene Cell 2009, 137, 835-48
55. Le Hellard, S.; Havik, B.; Espeseth, T.; Breilid, H.; Lovlie, R.; Luciano, M.; Gow, A. J.; Harris, S. E.; Starr, J. M.; Wibrand, K.; Lundervold, A. J.; Porteous, D. J.; Bramham, C. R.; Deary, I. J.; Reinvang, I.; Steen, V. M. Variants in doublecortin- and calmodulin kinase like 1, a gene up-regulated by BDNF, are associated with memory and general cognitive abilities PLoS One 2009, 4, e7534
56. Francis, F.; Koulakoff, A.; Boucher, D.; Chafey, P.; Schaar, B.; Vinet, M. C.; Friocourt, G.; McDonnell, N.; Reiner, O.; Kahn, A.; McConnell, S. K.; Berwald-Netter, Y.; Denoulet, P.; Chelly, J. Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons Neuron 1999, 23, 247-56
57. Barbie, D. A.; Tamayo, P.; Boehm, J. S.; Kim, S. Y.; Moody, S. E.; Dunn, I. F.; Schinzel, A. C.; Sandy, P.; Meylan, E.; Scholl, C.; Frohling, S.; Chan, E. M.; Sos, M. L.; Michel, K.; Mermel, C.; Silver, S. J.; Weir, B. A.; Reiling, J. H.; Sheng, Q.; Gupta, P. B.; Wadlow, R. C.; Le, H.; Hoersch, S.; Wittner, B. S.; Ramaswamy, S.; Livingston, D. M.; Sabatini, D. M.; Meyerson, M.; Thomas, R. K.; Lander, E. S.; Mesirov, J. P.; Root, D. E.; Gilliland, D. G.; Jacks, T.; Hahn, W. C. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 Nature 2009, 462, 108-12
58. Sarthy, A. V.; Morgan-Lappe, S. E.; Zakula, D.; Vernetti, L.; Schurdak, M.; Packer, J. C.; Anderson, M. G.; Shirasawa, S.; Sasazuki, T.; Fesik, S. W. Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells Mol. Cancer Ther. 2007, 6, 269-76
59. Scholl, C.; Frohling, S.; Dunn, I. F.; Schinzel, A. C.; Barbie, D. A.; Kim, S. Y.; Silver, S. J.; Tamayo, P.; Wadlow, R. C.; Ramaswamy, S.; Dohner, K.; Bullinger, L.; Sandy, P.; Boehm, J. S.; Root, D. E.; Jacks, T.; Hahn, W. C.; Gilliland, D. G. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells Cell 2009, 137, 821-34
60. Steckel, M.; Molina-Arcas, M.; Weigelt, B.; Marani, M.; Warne, P. H.; Kuznetsov, H.; Kelly, G.; Saunders, B.; Howell, M.; Downward, J.; Hancock, D. C. Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies Cell Res. 2012, 22, 1227-45